Histatin-resistant derivatives of Candida albicans strain 132A, generated by successive exposure to increasing concentrations of histatin-3 were previously reported to be similar to the parent strain in their histatin binding, internalization, oxygen consumption, ATP efflux and histatin degradation. Proteomic analysis of further histatin-resistant secondary derivatives of this series revealed that 59 proteins were differentially expressed compared to the parental strain. Of these 59 proteins, three were absent in histatin-resistant secondary derivatives and 11 were absent in the parent strain. Of the proteins absent in the histatin-resistant derivatives, the most notable was elongation factor 2 (Ef2), a target for the natural antifungal sordarin. Of the proteins absent in the parent strain but present in histatin-resistant derivatives, those identified included isocitrate lyase (Icl1p), Fructose biphosphate aldolase (Fba1p), pyruvate decarboxylase (Pdc2p) and ketol-acid reductoisomerase (Ilv5p). The present secondary derivatives showed significantly decreased rates of oxygen consumption and histatin-3-mediated ATP release compared to the parent strain and also showed stability of the histatin-resistant phenotype. A significant decrease in transcript levels of the potassium transporter encoded by TRK1, a critical mediator of histatin killing, was found in only one of the secondary histatinresistant derivatives compared to the parent strain. The sequential exposure of C. albicans to histatin-3 described here resulted in the induction or selection of a phenotype with impaired metabolic function. The results support an important role for metabolic pathways in the histatin-resistance mechanism and suggest that there may be several intracellular targets for histatin-3 in C. albicans.
INTRODUCTION
Oral candidiasis is a common infection caused predominantly by the opportunistic yeast pathogen Candida albicans, which is frequently a commensal of the oral cavity. The human innate immune system provides the first line of defence against infection with oral Candida species and the secreted antimicrobial proteins responsible for combating oral yeasts include the -defensins, lactoferrin, lysozyme and the salivary histatins. The histatins have potential as novel therapeutic antifungal agents and it has been known for some time that they differ in their mechanism of antifungal activity compared to the azole antifungal drugs, such as fluconazole and itraconazole, most commonly used therapeutically to treat Candida infection. The mechanism of action of histatin involves a multistep process initiated by binding to a yeast cell surface receptor, identified as heat shock protein Ssa2p (17, 18) . This is followed by internalization and interaction with intracellular targets such as the mitochondrion (8,10). Yeast cell killing in vitro correlates with the release of ATP, potassium and magnesium ions, mediated by the potassium transporter Trk1p (3) . We previously reported that histatin-resistant derivatives of C. albicans 132A (termed CAHR1 and CAHR4), generated by sequential exposure to increasing concentrations of histatin-3, were similar to their parental strain in their histatin binding, internalization and degradation and showed no difference in ATP efflux or oxygen consumption rates (4) . Since no difference in the histatin-killing mechanism of the histatin-resistant derivatives could be inferred from our previous study, the present study was undertaken in order to globally assess proteomic alterations between newly generated histatin-resistant derivatives and in the histatin-susceptible parent to identify (killing activity at 0.2 mg/ml histatin-3; CAHR1 = 86.4 % ± 9.4, CAHR4 = 94.4 ± 4.6 %) after storage at -80 o C for 1 year (reactivated by growth on potato dextrose agar (PDA) at 37 o C for 48 h). One of these primary derivatives, CAHR4 was therefore exposed to further sequential rounds of histatin-3 exposure as described previously (4) subjected to successive rounds of histatin-3 exposure as described above. The history of histatin exposure for the secondary histatin-resistant derivatives generated in this way is summarised in Table 1 . The secondary derivatives CAHR04A and CAHR04B were generated from CAHR4 following the exposure regime outlined. Secondary derivative CAHR04U was generated from CAHR04A following a further 4 consecutive rounds of histatin-3 exposure. Cells were counted using a haemocytometer and cell numbers adjusted by dilution.
Candidacidal assay of histatin-3. Histatin-3 (DSH/AKR/HHG/YKR/KFH/EKH/HSH/RGY/RSN/YLY/DN) was synthesized
commercially by JPT Peptide Technologies (Invalidenstrasse 130, 10115, Berlin, Germany). Candidacidal assays were carried out on the C. albicans parental strain CA132A and histatin-resistant derivatives as described previously (4) . Briefly, killing assays were performed in 1.5 ml microtubes in 100 l of 10 mM potassium phosphate buffer (PPB), pH 7.4, and contained 1 × 10 5 cells and 0-0.4 mg/ml histatin-3 (this range spans the physiological concentration of histatin reported in saliva (16) . The reaction was incubated for 1 h at 37 o C with vigorous mixing before adding 900 l of 0.9 % (w/v) NaCl, and 100 l of this dilution was spread onto PDA plates, followed by incubation at 37 C for 48 h. Killing activity was calculated as the number of colony forming units (CFU) on test plates as a percentage of CFU on plates incubated in the absence of histatin-3. Growth rate determination of CA132A and histatin-resistant derivatives. Two of the three secondary histain-resistant derivatives were selected for growth rate determination.
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Overnight cultures of CA132A and secondary histatin-resistant derivatives CAHR04A
and CAHR04B were adjusted to 1 × 10 5 cells/ml and 200 l aliquots were added to 96
well plates with flat-bottomed wells (Greiner Bio-One, Frickenhausen, Germany).
Increasing cell density was measured with time (20 h) as an increase in absorbance at 595 nm using a GENios model, Tecan spectrophotometer, (Crailsheim, Germany). The plates were set to shake continuously at normal intensity (instrument setting).
Stability of the histatin-resistant phenotype in derivatives. Two of the histatin resistant derivatives, CAHR04A and CAHR04B were subjected to ten consecutive subcultures on histatin-3-free PDA agar. Following subculture the derivatives recovered 6 
Measurement of histatin-mediated ATP release. The method of Ansehn and Nielson
(1) was used to measure the effect of histatin-3 on the release of ATP from overnight cultures of C. albicans CA132A, CAHR04A, CAHR04B and CAHR04U and was the same method used previously by us on the primary histatin resistant derivatives (3).
Briefly, C. albicans cells (1 x 10 6 ) were incubated with histatin 3 (0.2 mg/ml) for 45 min.
The reaction was centrifuged at 5000 × g for 5 min. A 25 l volume of supernatant was added to 210 l boiling TE buffer (50 mM Tris, 2 mM EDTA, pH 7.8), boiled for a further 4 min and stored on ice until ATP measurement. ATP levels were measured by luminometry using an ATP assay kit (Sigma-Aldrich, Ireland Ltd.). Luciferin-luciferase assay mix (2.5 mg/ml, 50 l) was added to 20 l of the extracellular material and the light CA132A using the calculation as described in the ABI users manual. The copy numbers for the TRK1 target were first normalized to the copy numbers obtained for EFB1. electrophoresis protocol based on the method of Klose and Kobalz (14) . After electrophoresis, gels were silver-stained for detection of protein spots using the method described by Heukeshoven and Dernick (11).
Image analysis.Two-dimensional image analysis was provided commercially by the Proteome Factory (Dorotheenstr. 94, D-10117 Berlin). The 2DE gels used for comparison analysis were digitised at a resolution of 150 dpi using a PowerLook 2100XL scanner with transparency adapter. Two-dimensional image analysis was performed using the Proteomweaver software (Definiens AG, Munich, Germany). Spot volumes were normalised against total spot volume and total spot area after background subtraction. 
RESULTS
DNA fingerprinting and phenotypic features of histatin-resistant derivatives. The
Ca3 probe is a moderately repetitive sequence used specifically to determine the clonal relationship between C. albicans isolates. It is routinely used for this purpose as it gives an accurate measure of the genetic distance between strains based on the hypervariability of genomic sequences homologous to the C fragment of the probe (19) . The parental strain CA132A, the histatin-resistant secondary derivatives generated during this study (CAHR04A, CAHR04B, CAHR04U) and the primary derivatives from our previous study (CAHR1, CAHR4 (4) Although the secondary histatin-resistant derivatives CAHR04A, CAHR04B and CAHR04U generated in this study produced smooth round white colonies similar to CA132A on PDA plates, they were approximately one third smaller compared to colonies of the parental strain and this reduced colony size was retained on repeated subculture.
Unlike CA132A, which produced colonies on medium containing glycerol as a carbon source and the classic petite mutant strain MMU11, which was incapable of growth on this medium, the secondary histatin-resistant derivatives grew very poorly on glycerollimited medium (produced colonies approximately 3 times smaller than those of CA132A and which were visible only after 4 days at 37 o C, data not shown) indicating that respiration was compromised compared to CA132A. Furthermore the histatin-resistant derivatives were shown to be distinct from a classical respiration deficient strain (MMU11) by producing pinkish colonies similar in colour to the parental strain CA132A on medium supplemented with trypan blue and eosin Y (Fig. 1) . The respiration-deficient strain MMU11 produced blue colonies on this medium.
Two of the three histatin-resistant secondary derivatives (CAHR04A and CAHR04B) were selected for growth rate determination and as shown in parental strain. At each concentration of histatin-3 studied, the derivatives were significantly less susceptible to histatin-3 than their parent strain CA132A. At 0.2 mg/ml histatin, which caused 91.7 % killing of CA132A only 17.9 -31.9 % killing activity was found for the histatin-resistant secondary derivatives ( Fig. 2A) .
The histatin-resistant phenotype of the primary derivatives CAHR1 and CAHR4 generated previously in this laboratory (4) was transient and colonies reverted to the histatin-susceptible phenotype after re-activation from frozen storage (killing activity at 0.2 mg /ml histatin-3; CAHR1 = 86.4 % ± 9.4, CAHR4 = 94.4 ± 4.6 %) or when subcultured in the absence of histatin up to three times (pre-cryopreservation). Two of the secondary histatin-resistant derivatives (CAHR04A and CAHR04B) were selected for determination of the stability of the histain-resistant phenotype. Both CAHR04A and CAHR04B, generated from the primary histatin-resistant derivative CAHR4, showed stability of the histatin-resistant phenotype even after 10 consecutive subcultures on histatin-3-free PDA agar (Fig. 2B) . Furthermore, the growth-rate of the secondary derivatives, CAHR04A and CAHR04B which was reduced compared to the parental strain CA132A, did not change after subculturing 10 times onto fresh PDA agar (Fig.   2C ).
Oxygen consumption measurement. The rates of oxygen consumption of histatinresistant primary and secondary derivatives and the parent strain CA132A are shown in Table 2 . Unlike the primary derivatives CAHR1 and CAHR4 (4) that exhibited an unstable histatin-resistant phenotype and showed no significant alteration in oxygen consumption rates compared to the parent strain, the oxygen consumption rates of all Histatin-mediated ATP release and TRK 1 transcript levels. As shown in Fig. 3B , the rate of histatin-mediated ATP release from the secondary histatin-resistant derivatives CAHR04A, CAHR04B and CAHR04U was significantly reduced compared to that found for the parental strain CA132A, after 45 min incubation with histatin-3. The reduction in ATP release was accompanied by a 2-fold and 1.6-fold reduction in expression of the potassium transporter transcript TRK1, for CAHR04A and CAHR04B, respectively, but no significant alteration in TRK1 expression was found for CAHR04U as shown by quantitative real-time PCR (Fig. 3A) .
Comparative proteomic analysis of CA132A and histatin-resistant derivatives.
Comparative 2D electrophoretic analysis of the proteome of the parental strain CA132A
with those of the secondary histatin-resistant derivatives CAHR04A, CAHR04B and For two of the 11 proteins, absent in the parental strain, CA132A, identification showed that they represented two different isoforms of the same protein (i.e. two isoforms of Fba1p and 2 isoforms of Pdc2p). Therefore in total, 12 proteins were identified (3 downregulated, 9 up-regulated) and the available information on these proteins is summarised in Table 3 .
DISCUSSION
The generation and characterisation of the primary histatin-resistant derivatives CAHR1 and CAHR4 was described in our previous paper on this subject (4). The earlier study showed that there was no difference in the ability of these derivatives to bind and internalise histatin-3, to degrade histatin-3 or to release intracellular ATP, when compared to the parent strain. On reactivation of these derivatives following storage at -80 o C for one year, the histatin-resistant phenotype was found to have been lost and therefore the secondary histatin-resistant derivatives described here were generated from the previously studied primary derivatives by further exposure to histatin-3. It is unclear why the primary histatin-resistant derivatives lost this phenotype after cryopreservation. The biochemical alterations leading to the histatin-resistant phenotype were investigated in secondary derivatives. In the present study a proteome-wide approach was employed to identify differentially expressed proteins in secondary histatin-resistant derivatives compared to the parent CA132A.
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Analysis of the three independent histatin-resistant secondary derivatives (CAHR04A, CAHR04B and CAHR04U) by 2D gel electrophoresis revealed 59 variant spots (from a possible 1400-1600) common to all three derivatives (20 down-regulated and 39 up-regulated). Identification of 12 of these differentially-regulated proteins (those that were absent in either the parent CA132A strain or absent in all three histatin-resistant secondary derivatives) revealed a number of interesting proteins the regulation of which may contribute to the reduced susceptibility of strains CAHR04A, CAHR04B and CAHR04U to histatin-3. The nature of the regulation of these proteins cannot be inferred from the proteomic data alone. To determine whether these proteins are regulated at the level of transcription or post-translationally would require gene/transcript analysis.
Future work in this area will involve transcript analysis using C. albicans specific DNA with trypan blue and eosin Y (Fig. 1) . On this medium, the respiratory mutants MMU11 appeared blue/violet whereas the histatin-resistant derivatives and the parent strain CA132A appeared pink on this medium. The ability of secondary histatin-resistant derivatives to grow, albeit poorly on glycerol-limited medium and to consume oxygen at significantly reduced rates suggest that, although these derivatives appear to be metabolically compromised having lesions in metabolically important proteins, they retain some mitochondrial function. markedly affected with oxygen consumption rates reduced to 17.1-34.6 % of that of the parent CA132A. Previously we found no difference in oxygen consumption rates in the histatin-resistant primary derivatives CAHR1, CAHR4 compared to the parent strain CA132A (3) and this was confirmed in the present study (Table 2) Orf19.7531 n/a n/a n/a n/a 
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